Journal
GENES AND IMMUNITY
Volume 10, Issue 2, Pages 120-124Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/gene.2008.85
Keywords
adrenal insufficiency; type 1 diabetes mellitus; NALP1; NLRP1; autoimmunity; single nucleotide polymorphism
Categories
Funding
- The Seventh Framework Programme 'Euradrenal,'
- The Western and South-Eastern Regional Health Authorities
- Norwegian Research Council
- University of Bergen
Ask authors/readers for more resources
Variants in the gene encoding NACHT leucine-rich-repeat protein 1 (NALP1), an important molecule in innate immunity, have recently been shown to confer risk for vitiligo and associated autoimmunity. We hypothesized that sequence variants in this gene may be involved in susceptibility to a wider spectrum of autoimmune diseases. Investigating large patient cohorts from six different autoimmune diseases, that is autoimmune Addison's disease (n = 333), type 1 diabetes (n = 1086), multiple sclerosis (n = 502), rheumatoid arthritis (n = 945), systemic lupus erythematosus (n = 156) and juvenile idiopathic arthritis (n = 505), against 3273 healthy controls, we analyzed four single nucleotide polymorphisms (SNPs) in NALP1. The major allele of the coding SNP rs12150220 revealed significant association with autoimmune Addison's disease compared with controls (OR = 1.25, 95% CI: 1.06-1.49, P = 0.007), and with type 1 diabetes (OR = 1.15, 95% CI: 1.04-1.27, P = 0.005). Trends toward the same associations were seen in rheumatoid arthritis, systemic lupus erythematosus and, although less obvious, multiple sclerosis. Patients with juvenile idiopathic arthritis did not show association with NALP1 gene variants. The results indicate that NALP1 and the innate immune system may be implicated in the pathogenesis of many autoimmune disorders, particularly organ-specific autoimmune diseases.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available